About
Small molecules with copper chelating properties
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
13
By Phase
NA: 1PHASE1: 1
By Status
RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05221359Lead Sponsor
Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
NARecruiting
8 participants
Started: May 5, 2022 · Completed: Apr 30, 2027
NCT02524951Collaborator
Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer
PHASE1Terminated
5 participants
Started: Apr 30, 2016 · Completed: May 14, 2018
Locations (1)
Headquarters
Farmingdale, NY, United States
Map
Loading map...